Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

The European Respiratory Review: continuing the success and targeting new challenges.

Adir Y.

Eur Respir Rev. 2019 Feb 6;28(151). pii: 190001. doi: 10.1183/16000617.0001-2019. Print 2019 Mar 31. No abstract available.

2.

COPD Exacerbator Phenotype is Inversely Associated with Current Smoking But Not with Haptoglobin Phenotype.

Tal S, Adir Y, Stein N, Shalom H, Lache O, Levy A, Shteinberg M.

Isr Med Assoc J. 2019 Jan;21(1):19-23.

3.

Circulating eosinophil levels do not predict severe exacerbations in COPD: a retrospective study.

Adir Y, Hakrush O, Shteinberg M, Schneer S, Agusti A.

ERJ Open Res. 2018 Aug 3;4(3). pii: 00022-2018. doi: 10.1183/23120541.00022-2018. eCollection 2018 Jul.

4.

EBUS-TBNA is Sufficient for Successful Diagnosis of Silicosis with Mediastinal Lymphadenopathy.

Shitrit D, Adir Y, Avriel A, King D, Epstein Shochet G, Guber A, Schnaer S, Kassirer M, Blanc PD, Abramovich A.

Lung. 2018 Aug;196(4):441-445. doi: 10.1007/s00408-018-0129-3. Epub 2018 May 29.

PMID:
29845341
5.

Association Between BMI and Obesity With Survival in Pulmonary Arterial Hypertension.

Weatherald J, Huertas A, Boucly A, Guignabert C, Taniguchi Y, Adir Y, Jevnikar M, Savale L, Jaïs X, Peng M, Simonneau G, Montani D, Humbert M, Sitbon O.

Chest. 2018 Oct;154(4):872-881. doi: 10.1016/j.chest.2018.05.006. Epub 2018 May 22.

PMID:
29800550
6.

Novel non-invasive early detection of lung cancer using liquid immunobiopsy metabolic activity profiles.

Adir Y, Tirman S, Abramovitch S, Botbol C, Lutaty A, Scheinmann T, Davidovits E, Arbel I, Davidovits G, Schneer S, Shteinberg M, Peretz Soroka H, Tirosh R, Patolsky F.

Cancer Immunol Immunother. 2018 Jul;67(7):1135-1146. doi: 10.1007/s00262-018-2173-5. Epub 2018 May 21.

PMID:
29785657
7.

Prevalence, risk factors and prognosis of nontuberculous mycobacterial infection among people with bronchiectasis: a population survey.

Shteinberg M, Stein N, Adir Y, Ken-Dror S, Shitrit D, Bendayan D, Fuks L, Saliba W.

Eur Respir J. 2018 May 10;51(5). pii: 1702469. doi: 10.1183/13993003.02469-2017. Print 2018 May. No abstract available.

PMID:
29545278
8.

[DIAGNOSIS AND TREATMENT OF BRONCHIECTASIS: POSITION PAPER OF THE ISRAELI PULMONOLOGY SOCIETY AND THE ISRAELI PEDIATRIC PULMONOLOGY SOCIETY].

Shteinberg M, Hardak E, Koslow M, Prais D, Cohen-Cymberkno M, Shoseyov D, Dagan A, Adir Y, Shitrit D.

Harefuah. 2018 Feb;157(2):117-121. Hebrew.

PMID:
29484869
9.

Upper airway involvement in bronchiectasis is marked by early onset and allergic features.

Shteinberg M, Nassrallah N, Jrbashyan J, Uri N, Stein N, Adir Y.

ERJ Open Res. 2018 Jan 19;4(1). pii: 00115-2017. doi: 10.1183/23120541.00115-2017. eCollection 2018 Jan.

10.

Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.

Weatherald J, Boucly A, Chemla D, Savale L, Peng M, Jevnikar M, Jaïs X, Taniguchi Y, O'Connell C, Parent F, Sattler C, Hervé P, Simonneau G, Montani D, Humbert M, Adir Y, Sitbon O.

Circulation. 2018 Feb 13;137(7):693-704. doi: 10.1161/CIRCULATIONAHA.117.029254. Epub 2017 Oct 25.

PMID:
29070502
11.

Palliative care in interstitial lung disease: living well.

Kreuter M, Bendstrup E, Russell AM, Bajwah S, Lindell K, Adir Y, Brown CE, Calligaro G, Cassidy N, Corte TJ, Geissler K, Hassan AA, Johannson KA, Kairalla R, Kolb M, Kondoh Y, Quadrelli S, Swigris J, Udwadia Z, Wells A, Wijsenbeek M.

Lancet Respir Med. 2017 Dec;5(12):968-980. doi: 10.1016/S2213-2600(17)30383-1. Epub 2017 Oct 13. Review.

12.

Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities.

Adir Y, Guazzi M, Offer A, Temporelli PL, Cannito A, Ghio S.

Am Heart J. 2017 Oct;192:120-127. doi: 10.1016/j.ahj.2017.06.006. Epub 2017 Jun 21.

PMID:
28938958
13.

[LONG TERM TREATMENT WITH MACROLIDES IN CHRONIC LUNG DISEASES].

Shteinberg M, Schneer S, Lavon O, Adir Y.

Harefuah. 2016 Sep;155(9):567-571. Review. Hebrew.

PMID:
28530085
14.

Can asthmatic subjects dive?

Adir Y, Bove AA.

Eur Respir Rev. 2016 Jun;25(140):214-20. doi: 10.1183/16000617.0006-2016. Review.

15.

Physiological Profile and Limitations in Exercise in Idiopathic Pulmonary Fibrosis.

Vainshelboim B, Oliveira J, Fox BD, Adir Y, Ollech JE, Kramer MR.

J Cardiopulm Rehabil Prev. 2016 Jul-Aug;36(4):270-8. doi: 10.1097/HCR.0000000000000177.

PMID:
27120038
16.

Spontaneous Resolution of Pulmonary Langerhans Cell Histiocytosis Despite Smoking.

Shteinberg M, Yeremekno D, Adir Y.

Lung. 2016 Apr;194(2):331-2. doi: 10.1007/s00408-016-9845-8. Epub 2016 Jan 21. No abstract available.

PMID:
26791193
17.

Risk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism among treated and untreated patients: a pooled analysis of 926 patients.

van der Hulle T, den Exter PL, Planquette B, Meyer G, Soler S, Monreal M, Jiménez D, Portillo AK, O'Connell C, Liebman HA, Shteinberg M, Adir Y, Tiseo M, Bersanelli M, Abdel-Razeq HN, Mansour AH, Donnelly OG, Radhakrishna G, Ramasamy S, Bozas G, Maraveyas A, Shinagare AB, Hatabu H, Nishino M, Huisman MV, Klok FA.

J Thromb Haemost. 2016 Jan;14(1):105-13. doi: 10.1111/jth.13172. Epub 2016 Jan 11.

18.

Pulmonary hypertension in patients with chronic myeloproliferative disorders.

Adir Y, Elia D, Harari S.

Eur Respir Rev. 2015 Sep;24(137):400-10. doi: 10.1183/16000617.0041-2015. Review.

19.

[BRONCHIECTASIS--REVIEW OF LITERATURE AND CLINICAL CHARACTERISTICS OF BRONCHIECTASIS PATIENTS TREATED IN THE BRONCHIECTASIS CLINIC AT THE CARMEL MEDICAL CENTER].

Shteinberg M, Yaari N, Stein N, Amital A, Israeli D, Adir Y.

Harefuah. 2015 Jun;154(6):356-61, 406, 405. Review. Hebrew.

PMID:
26281077
20.

The effect of pulmonary hypertension on aerobic exercise capacity in lung transplant candidates with advanced emphysema.

Adir Y, Ollech JE, Vainshelboim B, Shostak Y, Laor A, Kramer MR.

Lung. 2015 Apr;193(2):223-9. doi: 10.1007/s00408-015-9698-6. Epub 2015 Mar 7.

PMID:
25749664
21.

[Pulmonary hypertension in chronic lung diseases].

Seeger W, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs S, Martinez FJ, Semigran MJ, Simonneau G, Wells AU, Vachiéy JL.

Turk Kardiyol Dern Ars. 2014 Oct;42 Suppl 1:142-52. Turkish.

22.

[Pulmonary hypertension due to left heart diseases].

Vachiéry JL, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs JS, Martinez F, Semigran M, Simonneau G, Wells A, Seeger W.

Turk Kardiyol Dern Ars. 2014 Oct;42 Suppl 1:130-41. Turkish.

23.

Lung injury related to extreme environments.

Adir Y, Bove AA.

Eur Respir Rev. 2014 Dec;23(134):416-26. doi: 10.1183/09059180.00006214. No abstract available.

24.

Asymptomatic carriage of Pneumocystis jirovecii and cytomegalovirus in lungs of immunocompetent patients.

Shteinberg M, Shaked-Mishan P, Kinarti A, Abramovitch A, Amital A, Jacobi A, Kolup Feldmann AE, Shiner M, Gershtein V, Weber G, Adir Y.

Lung. 2014 Dec;192(6):875-9. doi: 10.1007/s00408-014-9644-z. Epub 2014 Sep 9.

PMID:
25201088
25.

Pulmonary hypertension associated with chronic obstructive lung disease and idiopathic pulmonary fibrosis.

Adir Y, Harari S.

Curr Opin Pulm Med. 2014 Sep;20(5):414-20. doi: 10.1097/MCP.0000000000000084. Review.

PMID:
25046428
26.

Pulmonary hypertension in chronic lung diseases.

Seeger W, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs S, Martinez FJ, Semigran MJ, Simonneau G, Wells AU, Vachiéry JL.

J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D109-16. doi: 10.1016/j.jacc.2013.10.036. Review.

27.

Pulmonary hypertension due to left heart diseases.

Vachiéry JL, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs JS, Martinez F, Semigran M, Simonneau G, Wells A, Seeger W.

J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D100-8. doi: 10.1016/j.jacc.2013.10.033. Review.

28.

The SomnuSeal Oral Mask Is Reasonably Tolerated by Otherwise CPAP Noncompliant Patients with OSA.

Katz N, Adir Y, Etzioni T, Kurtz E, Pillar G.

Sleep Disord. 2013;2013:840723. doi: 10.1155/2013/840723. Epub 2013 Oct 8.

29.

Pulmonary hypertension associated with left heart disease.

Adir Y, Amir O.

Semin Respir Crit Care Med. 2013 Oct;34(5):665-80. doi: 10.1055/s-0033-1356490. Epub 2013 Sep 13. Review.

PMID:
24037633
30.

Severe pulmonary hypertension associated with emphysema: a new phenotype?

Adir Y, Shachner R, Amir O, Humbert M.

Chest. 2012 Dec;142(6):1654-1658. doi: 10.1378/chest.11-2816.

PMID:
23208339
31.

The association between obesity, mortality and filling pressures in pulmonary hypertension patients; the "obesity paradox".

Zafrir B, Adir Y, Shehadeh W, Shteinberg M, Salman N, Amir O.

Respir Med. 2013 Jan;107(1):139-46. doi: 10.1016/j.rmed.2012.10.019. Epub 2012 Nov 28.

32.

Clinical characteristics and outcomes of patients with clinically unsuspected pulmonary embolism versus patients with clinically suspected pulmonary embolism.

Shteinberg M, Segal-Trabelsy M, Adir Y, Laor A, Vardi M, Bitterman H.

Respiration. 2012;84(6):492-500. doi: 10.1159/000342324. Epub 2012 Sep 15.

33.

Out-of-proportion pulmonary hypertension and heart failure with preserved ejection fraction.

Adir Y, Humbert M, Sitbon O, Wolf R, Lador F, Jaïs X, Simonneau G, Amir O.

Respiration. 2013;85(6):471-7. doi: 10.1159/000339595. Epub 2012 Aug 9.

34.

[Actinomyces empyema treated with decortications].

Shteinberg M, Perek S, Ghanem N, Sarafov I, Peysakhovich Y, Adir Y.

Harefuah. 2012 Apr;151(4):205-7, 254. Hebrew.

PMID:
22616146
35.

Telomere elongation followed by telomere length reduction, in leukocytes from divers exposed to intense oxidative stress--implications for tissue and organismal aging.

Shlush LI, Skorecki KL, Itzkovitz S, Yehezkel S, Segev Y, Shachar H, Berkovitz R, Adir Y, Vulto I, Lansdorp PM, Selig S.

Mech Ageing Dev. 2011 Mar;132(3):123-30. doi: 10.1016/j.mad.2011.01.005. Epub 2011 Feb 12.

PMID:
21320523
36.

The lung in rheumatoid arthritis.

Amital A, Shitrit D, Adir Y.

Presse Med. 2011 Jan;40(1 Pt 2):e31-48. doi: 10.1016/j.lpm.2010.11.003. Epub 2010 Dec 31. Review.

PMID:
21196098
37.

Flow resistance, work of breathing of humidifiers, and endotracheal tubes in the hyperbaric chamber.

Arieli R, Daskalovic Y, Ertracht O, Arieli Y, Adir Y, Abramovich A, Halpern P.

Am J Emerg Med. 2011 Sep;29(7):725-30. doi: 10.1016/j.ajem.2010.02.003. Epub 2010 May 1.

PMID:
20825878
38.

Pulmonary hypertension in patients with chronic myeloproliferative disorders.

Adir Y, Humbert M.

Eur Respir J. 2010 Jun;35(6):1396-406. doi: 10.1183/09031936.00175909. Review.

39.

Effects of a prolonged submersion on bone strength and metabolism in young healthy submariners.

Luria T, Matsliah Y, Adir Y, Josephy N, Moran DS, Evans RK, Abramovich A, Eliakim A, Nemet D.

Calcif Tissue Int. 2010 Jan;86(1):8-13. doi: 10.1007/s00223-009-9308-9. Epub 2009 Oct 31.

PMID:
19882096
40.

[The overlap syndrome: obstructive sleep apnea and chronic obstructive pulmonary disease].

Shteinberg M, Weiler-Ravel D, Adir Y.

Harefuah. 2009 May;148(5):333-6, 348. Review. Hebrew.

PMID:
19630366
41.

Overexpression of the Na-K-ATPase alpha2-subunit improves lung liquid clearance during ventilation-induced lung injury.

Adir Y, Welch LC, Dumasius V, Factor P, Sznajder JI, Ridge KM.

Am J Physiol Lung Cell Mol Physiol. 2008 Jun;294(6):L1233-7. doi: 10.1152/ajplung.00076.2007. Epub 2008 Apr 18.

42.

Pre-Labor exposure to carbon monoxide: should the neonate be treated with hyperbaric oxygenation?

Bar R, Cohen M, Bentur Y, Shupak A, Adir Y.

Clin Toxicol (Phila). 2007 Jun-Aug;45(5):579-81.

PMID:
17558632
43.

Hyperbaric oxygen in the treatment of sudden deafness.

Domachevsky L, Keynan Y, Shupak A, Adir Y.

Eur Arch Otorhinolaryngol. 2007 Aug;264(8):951-3. Epub 2007 Mar 15.

PMID:
17361409
44.

CO2 detection in closed-circuit oxygen divers with and without a distracting task.

Eynan M, Tal D, Arie E, Ne'eman F, Adir Y.

Aviat Space Environ Med. 2006 Oct;77(10):1028-33.

PMID:
17042247
45.

Hemodynamic effects of combined treatment with oxygen and hypertonic saline in hemorrhagic shock.

Brod VI, Krausz MM, Hirsh M, Adir Y, Bitterman H.

Crit Care Med. 2006 Nov;34(11):2784-91.

PMID:
16971851
46.

Alveolar fluid reabsorption is increased in rats with compensated heart failure.

Azzam ZS, Adir Y, Welch L, Chen J, Winaver J, Factor P, Krivoy N, Hoffman A, Sznajder JI, Abassi Z.

Am J Physiol Lung Cell Mol Physiol. 2006 Nov;291(5):L1094-100. Epub 2006 Jun 30.

47.

CNS toxicity in closed-circuit oxygen diving: symptoms reported from 2527 dives.

Arieli R, Shochat T, Adir Y.

Aviat Space Environ Med. 2006 May;77(5):526-32.

PMID:
16708533
48.

Adjuvant hyperbaric oxygenation therapy in hand edema and ischemia.

Kol S, Adir Y, Shupak A, Stahl S.

Tech Hand Up Extrem Surg. 1998 Dec;2(4):274-7. No abstract available.

PMID:
16609466
49.

Proteinuria on dipstick urine analysis after sexual intercourse.

Domachevsky L, Grupper M, Shochat T, Adir Y.

BJU Int. 2006 Jan;97(1):146-8.

50.

Inner ear decompression sickness and mal de debarquement.

Tal D, Domachevsky L, Bar R, Adir Y, Shupak A.

Otol Neurotol. 2005 Nov;26(6):1204-7.

PMID:
16272943

Supplemental Content

Support Center